CHARLESTON â The fourth week of Huntington and Cabell Countyâs opioid trial against three drug distributors was highlighted by an email showing McKesson Corp. employees cheering Appalachian trends shifting away from pills to illicit drugs in 2012.
The email was shared among McKesson employees, first by Tracey Jonas, director of regulatory processes, who shared a February 2012 article which said the DEA was seeing a sharp drop in Florida oxycodone.
Dave Gustin, a director of regulatory affairs, said pill users in Ohio and Kentucky were shifting to illicit drug use, such as heroin and meth. Jonas responded âGood . let them move to heroin and meth .we donât have to monitor that.â
CHARLESTON â The fourth week of Huntington and Cabell Countyâs opioid trial against three drug distributors was highlighted by an email showing McKesson Corp. employees cheering Appalachian trends shifting away from pills to illicit drugs in 2012.
The email was shared among McKesson employees, first by Tracey Jonas, director of regulatory processes, who shared a February 2012 article which said the DEA was seeing a sharp drop in Florida oxycodone.
Dave Gustin, a director of regulatory affairs, said pill users in Ohio and Kentucky were shifting to illicit drug use, such as heroin and meth. Jonas responded âGood . let them move to heroin and meth .we donât have to monitor that.â
Updated: 12:27 PM EDT May 28, 2021
BUFFALO, N.Y. A Williamsville doctor has agreed to pay $60,000 to resolve allegations that she violated the Controlled Substances Act.
Investigators say Dr. Nora Meaney-Elmen allegedly failed to safeguard the token and password used to e-prescribe controlled substances.
According to the release, between September 2015 and March 2018, Dr. Meaney-Elman f
ailed to safeguard her controlled substance prescribing token and password. As a result, her employee, Kristy Brucz, used the token and password to write 156 illegal prescriptions for controlled substances.
““As its name implies, the Controlled Substance Act is premised on the notion that the prescribing and distribution of certain dangerous and/or addictive substances must be controlled,” noted U.S. Attorney James P. Kennedy. “When those entrusted with such control fail to safeguard their prescribing credentials as Dr. Meaney-Elman did here the entire regulatory sc
Image courtesy of Flickr user symic A new special report by Powder & Bulk Solids and Packaging Digest offers a look at the scale of America s cannabis manufacturing industry.
Traditionally there were only three types of cannabis products available to most consumers on the black market: Flower, hash, and homemade edibles. While flower remains the top-selling product category in today’s legal market, production of concentrates and infused foods and beverages has become more sophisticated over the years, and a much wider array of tetrahydrocannabinol (THC) containing goods – from transdermal patches to dry powder inhalers – are now accessible.
In tandem with the rise of the legal marijuana industry, restrictions on hemp cultivation have loosened in the United States and elsewhere, as demand for non-psychoactive cannabidiol (CBD) grows at a tremendous clip. Like THC, CBD is now used as an ingredient in edibles, vapes, tinctures, and other packaged produ
CHARLESTON â Emails between McKesson employees showed the drug firmâs directors would sometimes approve 80 pharmacy requests to increase opioid shipment limits per day, all while the Drug Enforcement Administration in 2008 reported finding 4,600 suspicious order violations within the corporation.
Testimony over the communication was heard Monday at a federal trial born out of Cabell County and Huntingtonâs accusations the âBig Threeâ drug wholesalers â AmerisourceBergen, Cardinal Health and McKesson â fueled the regionâs opioid crisis by sending an excessive 127.9 million opiate doses into the region from 2006 to 2014 before a reduction in the pills shipped made users turn to illicit drugs.
The defendants point to the DEA, doctors and West Virginiansâ poor health as the culprits.